Cargando…

Sensitivity of Human Cancer Cells to the New Anticancer Ribo‐nucleoside TAS–106 Is Correlated with Expression of Uridine‐cytidine Kinase 2

TAS–106 [l–(3–C‐ethynyl‐β‐d‐ribo‐pentofuranosyl)cytosine] is a new anticancer ribo‐nucleoside with promising antitumor activity. We have previously presented evidence suggesting that the TAS–106 sensitivity of cells is correlated with intracellular accumulation of the triphosphate of TAS–106, which...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shimamoto, Yuji, Koizumi, Katsuhisa, Okabe, Hiroyuki, Kazuno, Hiromi, Murakami, Yuko, Nakagawa, Fumio, Matsuda, Akira, Sasaki, Takuma, Fukushima, Masakazu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2002
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5927072/ https://www.ncbi.nlm.nih.gov/pubmed/12149149 http://dx.doi.org/10.1111/j.1349-7006.2002.tb01325.x

Ejemplares similares

Cellular and Biochemical Mechanisms of the Resistance of Human Cancer Cells to a New Anticancer Ribo‐nucleoside, TAS‐106
por: Shimamoto, Yuji, et al.
Publicado: (2002)

Antitumor Activity and Pharmacokinetics of TAS‐106, l‐(3‐C‐Ethynyl‐β‐D‐ribo‐pentofuranosyl)cytosine
por: Shimamoto, Yuji, et al.
Publicado: (2001)

A nucleoside anticancer drug, 1-(3-C-ethynyl-β-D-ribo-pentofuranosyl)cytosine (TAS106), sensitizes cells to radiation by suppressing BRCA2 expression
por: Meike, Shunsuke, et al.
Publicado: (2011)

Indispensable residue for uridine binding in the uridine-cytidine kinase family
por: Tomoike, Fumiaki, et al.
Publicado: (2017)

Characterization of uridine-cytidine kinase like-1 nucleoside kinase activity and its role in tumor growth
por: Matchett, Emily C., et al.
Publicado: (2022)

The Cytidine Analog Fluorocyclopentenylcytosine (RX-3117) Is Activated by Uridine-Cytidine Kinase 2
por: Sarkisjan, Dzjemma, et al.
Publicado: (2016)

Comparative Nucleosomal Reactivity of 5‐Formyl‐Uridine and 5‐Formyl‐Cytidine
por: Runtsch, Leander Simon, et al.
Publicado: (2021)

Repeated oral dosing of TAS-102 confers high trifluridine incorporation into DNA and sustained antitumor activity in mouse models
por: TANAKA, NOZOMU, et al.
Publicado: (2014)

Overexpression of Uridine-Cytidine Kinase 2 Correlates with Breast Cancer Progression and Poor Prognosis
por: Shen, Guosong, et al.
Publicado: (2017)

In Silico Discovery of Potential Uridine-Cytidine Kinase 2 Inhibitors from the Rhizome of Alpinia mutica
por: Malami, Ibrahim, et al.
Publicado: (2016)

Reparameterization of RNA χ Torsion Parameters for the AMBER Force Field and Comparison to NMR Spectra for Cytidine and Uridine
por: Yildirim, Ilyas, et al.
Publicado: (2010)

Uridine-cytidine kinase 2 promotes metastasis of hepatocellular carcinoma cells via the Stat3 pathway
por: Zhou, Qiming, et al.
Publicado: (2018)

Uridine‐cytidine kinase 2 (UCK2): A potential diagnostic and prognostic biomarker for lung cancer
por: Wu, Yingjie, et al.
Publicado: (2019)

Analogues of Muraymycin Nucleoside Antibiotics with Epimeric Uridine-Derived Core Structures
por: Spork, Anatol P., et al.
Publicado: (2018)

Cytidine deaminases catalyze the conversion of N(S,O)(4)-substituted pyrimidine nucleosides
por: Urbelienė, Nina, et al.
Publicado: (2023)

Inhibition of HIF-1α by the anticancer drug TAS106 enhances X-ray-induced apoptosis in vitro and in vivo
por: Yasui, H, et al.
Publicado: (2008)

RiboFlow, RiboR and RiboPy: an ecosystem for analyzing ribosome profiling data at read length resolution
por: Ozadam, Hakan, et al.
Publicado: (2020)

Variable Frequency of Plastid RNA Editing among Ferns and Repeated Loss of Uridine-to-Cytidine Editing from Vascular Plants
por: Guo, Wenhu, et al.
Publicado: (2015)

Phase I dose-escalating study of TAS-106 in combination with carboplatin in patients with solid tumors
por: Naing, Aung, et al.
Publicado: (2013)

Uridine Cytidine Kinase Like-1 Enhances Tumor Cell Proliferation and Mediates Protection from Natural Killer-Mediated Killing
por: Gullickson, Gail, et al.
Publicado: (2016)

Detection of RNA nucleoside modifications with the uridine-specific ribonuclease MC1 from Momordica charantia
por: Addepalli, Balasubrahmanym, et al.
Publicado: (2015)

Enzymatic synthesis of nucleoside analogues from uridines and vinyl esters in a continuous-flow microreactor
por: Du, Li-Hua, et al.
Publicado: (2018)

RiboProfiling: a Bioconductor package for standard Ribo-seq pipeline processing
por: Popa, Alexandra, et al.
Publicado: (2016)

RiboPlotR: a visualization tool for periodic Ribo-seq reads
por: Wu, Hsin-Yen Larry, et al.
Publicado: (2021)

Curcumin modulates the apolipoprotein B mRNA editing by coordinating the expression of cytidine deamination to uridine editosome components in primary mouse hepatocytes
por: He, Pan, et al.
Publicado: (2019)

Nucleotides Cytidine and Uridine Associated with Vitamin B12 vs B-Complex Vitamins in the Treatment of Low Back Pain: The NUBES Study
por: Mibielli, Marco Antonio Naslausky, et al.
Publicado: (2020)

Synthesis and surface characterization of new triplex polymer of Ag(I) and mixture nucleosides: cytidine and 8-bromoguanosine
por: Al-mahamad, Lamia L.G.
Publicado: (2019)

Nucleolipids of Canonical Purine ß‐d‐Ribo‐Nucleosides: Synthesis and Cytostatic/Cytotoxic Activities Toward Human and Rat Glioblastoma Cells
por: Knies, Christine, et al.
Publicado: (2015)

Application of the uridine auxotrophic host and synthetic nucleosides for a rapid selection of hydrolases from metagenomic libraries
por: Urbelienė, Nina, et al.
Publicado: (2018)

Expression Levels of the Uridine-Cytidine Kinase Like-1 Protein As a Novel Prognostic Factor for Hepatitis C Virus-Associated Hepatocellular Carcinomas
por: Buivydiene, A., et al.
Publicado: (2017)

Targeting uridine–cytidine kinase 2 induced cell cycle arrest through dual mechanism and could improve the immune response of hepatocellular carcinoma
por: Wu, Dehai, et al.
Publicado: (2022)

RiboDiPA: a novel tool for differential pattern analysis in Ribo-seq data
por: Li, Keren, et al.
Publicado: (2020)

Ribo-ODDR: oligo design pipeline for experiment-specific rRNA depletion in Ribo-seq
por: Alkan, Ferhat, et al.
Publicado: (2021)

Efficacy of combination chemotherapy using a novel oral chemotherapeutic agent, TAS-102, together with bevacizumab, cetuximab, or panitumumab on human colorectal cancer xenografts
por: TSUKIHARA, HIROSHI, et al.
Publicado: (2015)

Palladium-catalyzed C–H olefination of uridine, deoxyuridine, uridine monophosphate and uridine analogues
por: Zhao, Qin, et al.
Publicado: (2022)

Investigation of acyclic uridine amide and 5′-amido nucleoside analogues as potential inhibitors of the Plasmodium falciparum dUTPase()
por: Hampton, Shahienaz E., et al.
Publicado: (2013)

Muraymycin nucleoside-peptide antibiotics: uridine-derived natural products as lead structures for the development of novel antibacterial agents
por: Wiegmann, Daniel, et al.
Publicado: (2016)

RiboStreamR: a web application for quality control, analysis, and visualization of Ribo-seq data
por: Perkins, Patrick, et al.
Publicado: (2019)

Screening of Differentially Expressed Genes in 5‐Fluorouracil‐resistant Human Gastrointestinal Tumor Cells
por: Takechi, Teiji, et al.
Publicado: (2001)

Phase II study of TAS-106 in patients with platinum-failure recurrent or metastatic head and neck cancer and nasopharyngeal cancer
por: Tsao, Anne, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_f7vhkbfoavauc7hnh1241lrvct